These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 23399899
1. Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients. Gidaro T, Negroni E, Perié S, Mirabella M, Lainé J, Lacau St Guily J, Butler-Browne G, Mouly V, Trollet C. J Neuropathol Exp Neurol; 2013 Mar; 72(3):234-43. PubMed ID: 23399899 [Abstract] [Full Text] [Related]
2. Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: Therapeutic perspectives of autologous myoblast transplantation. Périé S, Mamchaoui K, Mouly V, Blot S, Bouazza B, Thornell LE, St Guily JL, Butler-Browne G. Neuromuscul Disord; 2006 Nov; 16(11):770-81. PubMed ID: 17005403 [Abstract] [Full Text] [Related]
4. [Oculopharyngeal muscular dystrophy: study of patients from seven Spanish families with different GCG expansions in PABP2 gene]. Pou Serradell A, Lloreta Trull J, Corominas Torres JM, Hammouda EH, Urtizberea JA, Richard P, Brais B. Neurologia; 2004 Jun; 19(5):239-47. PubMed ID: 15150706 [Abstract] [Full Text] [Related]
6. Established PABPN1 intranuclear inclusions in OPMD muscle can be efficiently reversed by AAV-mediated knockdown and replacement of mutant expanded PABPN1. Malerba A, Klein P, Lu-Nguyen N, Cappellari O, Strings-Ufombah V, Harbaran S, Roelvink P, Suhy D, Trollet C, Dickson G. Hum Mol Genet; 2019 Oct 01; 28(19):3301-3308. PubMed ID: 31294444 [Abstract] [Full Text] [Related]
8. Cytoplasmic targeting of mutant poly(A)-binding protein nuclear 1 suppresses protein aggregation and toxicity in oculopharyngeal muscular dystrophy. Abu-Baker A, Laganiere S, Fan X, Laganiere J, Brais B, Rouleau GA. Traffic; 2005 Sep 01; 6(9):766-79. PubMed ID: 16101680 [Abstract] [Full Text] [Related]
9. Study of a Taiwanese family with oculopharyngeal muscular dystrophy. Kuo HC, Chen CM, Lee-Chen GJ, Hu FJ, Chu CC, Liou CW, Huang CC. J Neurol Sci; 2009 Mar 15; 278(1-2):21-4. PubMed ID: 19101703 [Abstract] [Full Text] [Related]
10. Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres. Trollet C, Anvar SY, Venema A, Hargreaves IP, Foster K, Vignaud A, Ferry A, Negroni E, Hourde C, Baraibar MA, 't Hoen PA, Davies JE, Rubinsztein DC, Heales SJ, Mouly V, van der Maarel SM, Butler-Browne G, Raz V, Dickson G. Hum Mol Genet; 2010 Jun 01; 19(11):2191-207. PubMed ID: 20207626 [Abstract] [Full Text] [Related]
11. Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy. Hino H, Araki K, Uyama E, Takeya M, Araki M, Yoshinobu K, Miike K, Kawazoe Y, Maeda Y, Uchino M, Yamamura K. Hum Mol Genet; 2004 Jan 15; 13(2):181-90. PubMed ID: 14645203 [Abstract] [Full Text] [Related]
15. Intranuclear Aggregates Precede Clinical Onset in Oculopharyngeal Muscular Dystrophy. van der Sluijs BM, Raz V, Lammens M, van den Heuvel LP, Voermans NC, van Engelen BG. J Neuromuscul Dis; 2016 Mar 03; 3(1):101-109. PubMed ID: 27854203 [Abstract] [Full Text] [Related]
16. Analysis of growth factor expression in affected and unaffected muscles of oculo-pharyngeal muscular dystrophy (OPMD) patients: a pilot study. Bouazza B, Kratassiouk G, Gjata B, Perie S, Lacau St Guily J, Butler-Browne GS, Svinartchouk F. Neuromuscul Disord; 2009 Mar 03; 19(3):199-206. PubMed ID: 19185491 [Abstract] [Full Text] [Related]